Stacey Gabriel is director of the Genomics Platform at the Broad Institute of MIT and Harvard. Under Gabriel’s guidance, the Genomics Platform explores, validates, optimizes, and implements new technologies, methods, and analysis tools to meet the needs of the Broad community. Gabriel and the members of her team are committed to pushing the boundaries of the genomic frontier through the application of operational excellence, advanced process design, data analysis and visualization, and technology development capabilities.
In addition to her activities with the Genomics Platform, Gabriel’s research interests lie in using genomic techniques to understand the genetic component of common disease. She has represented the Broad in many large national projects, including providing foundational research for the International HapMap Project; serving on the steering committee for the 1000 Genomes Project, as well as co-chairing the project’s production group; serving on the steering committee for The Cancer Genome Atlas; serving as principal investigator on the National Heart, Lung and Blood Institute’s Exome Sequencing Project; and co-principal investigator (with Eric Lander) of the National Human Genome Research Institute’s large-scale sequencing center at the Broad Institute. She has also served as principal investigator on eight NIH grants, totaling over $200 M, related to large-scale genotyping, sequence production, and analysis.
Gabriel joined the Whitehead Institute/MIT Center for Genome Research in 1998, where she successfully led the center’s contribution to the SNP Consortium Allele Frequency project.
Gabriel received her B.S. in molecular biology from Carnegie Mellon University and Ph.D. in human genetics from Case Western Reserve University.